Non-communicable Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
Department of Biochemistry, Faculty of Biological Sciences, Tarbiat Modares University, Tehran, Iran.
J Int Med Res. 2022 Oct;50(10):3000605221117134. doi: 10.1177/03000605221117134.
Individual studies in the Eastern Mediterranean Region (EMR) have shown the high prevalence of diabetic retinopathy. We conducted a meta-analysis to yield an estimate of the prevalence of diabetic (type 1 and 2) retinopathy in the EMR. Additionally, we explored its potential modulators.
Two-step screening of relevant articles published from 1 January 2000 to 13 December 2019 was carried out. An estimation of summary proportions, subgroup analysis, meta-regression, and publication bias assessment were performed.
One hundred nine articles were included in the meta-analysis, involving 280,566 patients. The prevalence of diabetic retinopathy was 31% (95% confidence interval [CI] = 28, 33). The highest and lowest diabetic retinopathy prevalence rates were observed in low human development index (HDI) countries (63.6; 95% CI = 52.4, 74.0) and very high HDI countries 22.6 (95% CI = 20.5, 24.7), respectively.
The prevalence of diabetic retinopathy is high in the EMR. Our results provide important information for diverse healthcare surveillance systems in the EMR to implement the modifiable risk factors, diabetes screening to decrease undiagnosed diabetes, early detection of retinopathy, and proper diabetes care to decrease untreated diabetes.
东地中海地区(EMR)的个别研究表明,糖尿病视网膜病变的患病率很高。我们进行了一项荟萃分析,以估算 EMR 中糖尿病(1 型和 2 型)视网膜病变的患病率。此外,我们还探讨了其潜在的调节剂。
对 2000 年 1 月 1 日至 2019 年 12 月 13 日期间发表的相关文章进行了两步筛选。进行了汇总比例估计、亚组分析、荟萃回归和发表偏倚评估。
共有 109 篇文章纳入荟萃分析,涉及 280566 名患者。糖尿病视网膜病变的患病率为 31%(95%置信区间[CI] = 28,33)。最低和最高的糖尿病视网膜病变患病率分别出现在人类发展指数(HDI)较低的国家(63.6%;95%CI = 52.4,74.0)和 HDI 非常高的国家 22.6%(95%CI = 20.5,24.7)。
EMR 中糖尿病视网膜病变的患病率很高。我们的研究结果为 EMR 中不同的医疗保健监测系统提供了重要信息,以实施可改变的危险因素、糖尿病筛查以减少未确诊的糖尿病、早期发现视网膜病变以及适当的糖尿病护理以减少未治疗的糖尿病。